IJR
iShares Core S&P Small Cap ETF
The iShares S&P SmallCap 600 Index Fund seeks investment results that correspond to the price and yield performance of the S&P SmallCap 600 Index. The index consists of the smallest stocks in the S&P U.S. universe.
US
EQUITY
Passive
MANAGEMENT STYLE
$ 109.7 B
ASSETS UNDER MGMT
6 bp
EXPENSES
Fund Basics
| Inception date | May 22, 2000 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| MOLINA HEALTHCARE INC | 0.6 % |
| PLATFORM SPECIALTY PRODUCTS | 0.6 % |
| VIASAT INC | 0.5 % |
| KRYSTAL BIOTECH, INC. | 0.5 % |
| GLAUKOS CORP | 0.5 % |
| MATCH GROUP, INC. | 0.5 % |
| ALKERMES PLC | 0.5 % |
| CORCEPT THERAPEUTICS INC | 0.5 % |
| PROTAGONIST THERAPEUTICS, INC. | 0.5 % |
| ESCO TECHNOLOGIES INC | 0.5 % |
Constituent Breakdown
| Number of holdings | 640 |
| Herfindahl-Hirschman Index | 22 |
| Wgt avg mkt cap (mns) | $4,164 |
| Large cap (>$10bn) | 2.9% |
| Mid cap ($2-10bn) | 75.9% |
| Small cap (<$2bn) | 13.4% |
| Developed mkts. | 93.1% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 91.4 % |
 |
IRELAND | 0.7 % |
 |
BERMUDA | 0.5 % |
Historical Performance
Standardized Performance (as of 06/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 23.4% | 35.7% | 17.9% | 14.2% | 5.6% | 9.8% | 8.1% | 8.9% |
| Dividend Yield | 0.6% | 1.8% | 2.0% | 1.8% | 1.7% | 1.6% | 1.5% | 1.4% |
| Total Returns | 24.0% | 37.5% | 19.9% | 16.0% | 7.3% | 11.5% | 9.6% | 10.3% | Ann. Volatility | 17.2% | 17.7% | 21.2% | 20.3% | 21.4% | 22.9% | 23.9% | 23.1% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.05 | 56% |
| MSCI EAFE | 0.79 | 48% |
| MSCI Emg Mkts | 0.46 | 36% |
Liquidity Measures
| Avg. volume (000) | 3,630 |
| ADV traded (mns) | $530 |
| Turnover | 0.5% |
| Avg. Bid/Ask (% of price) | 0.01% |
Technical Indicators
| 30d moving avg. (EMA) | $143.83 |
| Relative strength (RSI) | 59 |
| MACD/Signal | 1.42/1.71 |
| Bollinger Bands (Upper/Lower) | $148.77/$142.60 |
| Short interest (% of AUM) | 0.4% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. IJR |
Expenses vs. IJR |
ALTAR Score™ vs. IJR |
|---|---|---|---|---|
| SPSM | State Street SPDR Portfolio S&P 600 Small Cap ETF | 93.1% | -3 bp | +0.1% |
| VIOO | Vanguard S&P Small-Cap 600 ETF | 92.1% | +1 bp | -0.2% |
| XJR | iShares ESG Screened S&P Small-Cap ETF | 82.6% | +6 bp | -0.2% |
| QVMS | Invesco S&P SmallCap 600 QVM Multi-factor ETF | 76.8% | +9 bp | -0.1% |
| SLYV | State Street SPDR S&P 600 Small Cap Value ETF | 60.7% | +9 bp | +2.1% |
| IJS | iShares S&P Small-Cap 600 Value ETF | 60.5% | +12 bp | +2.0% |
| VIOV | Vanguard S&P Small-Cap 600 Value ETF | 60.3% | +4 bp | +2.1% |
| SLYG | State Street SPDR S&P 600 Small Cap Growth ETF | 58.9% | +9 bp | -2.1% |
| IJT | iShares S&P Small-Cap 600 Growth ETF | 58.8% | +12 bp | -2.1% |
| VIOG | Vanguard S&P Small-Cap 600 Growth ETF | 58.1% | +4 bp | -2.2% |
Risk and Returns: IJR vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 7/20/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.5%
ALTAR SCORE™
70th
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 1,401 funds in the US Equity category with an average
ALTAR Score™ of 5.4% and a standard deviation
of 2.1%. IJR's ALTAR Score™ is approximately 0.5 standard
deviations above the category average. This places IJR in the 70th percentile
among funds in the category.
Sell-Side Consensus
$155.87
PRICE TARGET
+6.7%
UPSIDE